JAMA, ISSN 0098-7484, 03/2007, Volume 297, Issue 12, pp. 1354 - 1361
CONTEXT Prosthetic valve endocarditis (PVE) is associated with significant mortality and morbidity. The contemporary clinical profile and outcome of PVE are...
MORTALITY | ACQUIRED INFECTIONS | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | MEDICAL PROGRESS | RISK-FACTORS | DUKE CRITERIA | ADULTS | FOLLOW-UP | INFECTIVE ENDOCARDITIS | PROPENSITY ANALYSIS | Prevalence | Prognosis | Prospective Studies | Prosthesis-Related Infections - epidemiology | Hospital Mortality | Humans | Middle Aged | Heart Valve Prosthesis - adverse effects | Male | Endocarditis, Bacterial - epidemiology | Staphylococcal Infections - epidemiology | Female | Registries | Aged | Cross Infection - epidemiology | Infective endocarditis | Care and treatment | Diagnosis | Research | Staphylococcal infections | Risk factors | Prostheses | Transplants & implants | Heart surgery | Mortality | Medical prognosis | Cardiovascular disease | Infections | Criteria | Bacterial | Heart Valve Prosthesis | Infektionsmedicin | Cross Infection | Staphylococcal Infections | epidemiology | Prosthesis-Related Infections | Endocarditis | Infectious Medicine | adverse effects
MORTALITY | ACQUIRED INFECTIONS | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | MEDICAL PROGRESS | RISK-FACTORS | DUKE CRITERIA | ADULTS | FOLLOW-UP | INFECTIVE ENDOCARDITIS | PROPENSITY ANALYSIS | Prevalence | Prognosis | Prospective Studies | Prosthesis-Related Infections - epidemiology | Hospital Mortality | Humans | Middle Aged | Heart Valve Prosthesis - adverse effects | Male | Endocarditis, Bacterial - epidemiology | Staphylococcal Infections - epidemiology | Female | Registries | Aged | Cross Infection - epidemiology | Infective endocarditis | Care and treatment | Diagnosis | Research | Staphylococcal infections | Risk factors | Prostheses | Transplants & implants | Heart surgery | Mortality | Medical prognosis | Cardiovascular disease | Infections | Criteria | Bacterial | Heart Valve Prosthesis | Infektionsmedicin | Cross Infection | Staphylococcal Infections | epidemiology | Prosthesis-Related Infections | Endocarditis | Infectious Medicine | adverse effects
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2013, Volume 8, Issue 5, p. e63181
The HACEK organisms (Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species) are rare causes of...
STROKE | DIAGNOSIS | MANAGEMENT | PROFILE | ANTIMICROBIAL THERAPY | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | GUIDELINES | STAPHYLOCOCCUS-AUREUS | HEALTH-CARE PROFESSIONALS | REFERRAL BIAS | Endocarditis, Bacterial - physiopathology | Prevalence | Age Factors | Haemophilus | Kingella | Humans | Treatment Outcome | Eikenella corrodens | Aggregatibacter | Cardiobacterium | Endocarditis, Bacterial - epidemiology | Statistics, Nonparametric | Endocarditis, Bacterial - microbiology | Odds Ratio | Endocarditis, Bacterial - therapy | Cohort Studies | Heart failure | Medical research | Implants, Artificial | Prosthesis | Patient outcomes | Mortality | Medicine, Experimental | Infective endocarditis | Comparative analysis | Epidemiology | Heart | Prostheses | Pathogens | Mitral valve | Stroke | Laboratories | Review boards | Bias | Medical services | Hospitalization | Congestive heart failure | Patients | Rare species | Infectious diseases | Hospitals | International cooperation | Antibiotics | Collaboration | Surgery | Endocarditis | Cardiology | Species | Life Sciences | Microbiology and Parasitology | Immunology | Infectious Medicine | Infektionsmedicin
STROKE | DIAGNOSIS | MANAGEMENT | PROFILE | ANTIMICROBIAL THERAPY | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | GUIDELINES | STAPHYLOCOCCUS-AUREUS | HEALTH-CARE PROFESSIONALS | REFERRAL BIAS | Endocarditis, Bacterial - physiopathology | Prevalence | Age Factors | Haemophilus | Kingella | Humans | Treatment Outcome | Eikenella corrodens | Aggregatibacter | Cardiobacterium | Endocarditis, Bacterial - epidemiology | Statistics, Nonparametric | Endocarditis, Bacterial - microbiology | Odds Ratio | Endocarditis, Bacterial - therapy | Cohort Studies | Heart failure | Medical research | Implants, Artificial | Prosthesis | Patient outcomes | Mortality | Medicine, Experimental | Infective endocarditis | Comparative analysis | Epidemiology | Heart | Prostheses | Pathogens | Mitral valve | Stroke | Laboratories | Review boards | Bias | Medical services | Hospitalization | Congestive heart failure | Patients | Rare species | Infectious diseases | Hospitals | International cooperation | Antibiotics | Collaboration | Surgery | Endocarditis | Cardiology | Species | Life Sciences | Microbiology and Parasitology | Immunology | Infectious Medicine | Infektionsmedicin
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 12/2007, Volume 147, Issue 12, pp. 829 - 835
Background: Infective endocarditis caused by non-HACEK (species other than Haemophilus species, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis,...
DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | INTERNATIONAL-COLLABORATION | PROSTHETIC VALVE ENDOCARDITIS | LEFT-SIDED ENDOCARDITIS | MANAGEMENT | PSEUDOMONAS-AERUGINOSA | BACTEREMIA | PROGRESS | INFECTIVE ENDOCARDITIS | DETROIT-MEDICAL-CENTER | Community-Acquired Infections - therapy | Cross Infection - therapy | Prospective Studies | Gram-Negative Bacteria | Humans | Treatment Outcome | Gram-Negative Bacterial Infections - therapy | Prostheses and Implants - microbiology | Gram-Negative Bacterial Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Cardiac Surgical Procedures | Endocarditis, Bacterial - epidemiology | Cross Infection - microbiology | Endocarditis, Bacterial - microbiology | Gram-Negative Bacterial Infections - epidemiology | Community-Acquired Infections - microbiology | Endocarditis, Bacterial - therapy | Substance Abuse, Intravenous - microbiology | Intravenous drug abuse | Distribution | Causes of | Cross infection | Nosocomial infections | Endocarditis, Bacterial | Health aspects
DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | INTERNATIONAL-COLLABORATION | PROSTHETIC VALVE ENDOCARDITIS | LEFT-SIDED ENDOCARDITIS | MANAGEMENT | PSEUDOMONAS-AERUGINOSA | BACTEREMIA | PROGRESS | INFECTIVE ENDOCARDITIS | DETROIT-MEDICAL-CENTER | Community-Acquired Infections - therapy | Cross Infection - therapy | Prospective Studies | Gram-Negative Bacteria | Humans | Treatment Outcome | Gram-Negative Bacterial Infections - therapy | Prostheses and Implants - microbiology | Gram-Negative Bacterial Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Cardiac Surgical Procedures | Endocarditis, Bacterial - epidemiology | Cross Infection - microbiology | Endocarditis, Bacterial - microbiology | Gram-Negative Bacterial Infections - epidemiology | Community-Acquired Infections - microbiology | Endocarditis, Bacterial - therapy | Substance Abuse, Intravenous - microbiology | Intravenous drug abuse | Distribution | Causes of | Cross infection | Nosocomial infections | Endocarditis, Bacterial | Health aspects
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 05/2009, Volume 150, Issue 9, p. 586
Background: The clinical profile and outcome of nosocomial and non-nosocomial health careâassociated native valve endocarditis are not well defined....
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.